- Home
- TCRT vs SXTP Comparison
TCRT vs SXTP Comparison
Compare TCRT & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRT
- SXTP
- Stock Information
- Founded
- TCRT 1998
- SXTP 2010
- Country
- TCRT United States
- SXTP United States
- Employees
- TCRT N/A
- SXTP N/A
- Industry
- TCRT Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- TCRT Health Care
- SXTP Health Care
- Exchange
- TCRT Nasdaq
- SXTP Nasdaq
- Market Cap
- TCRT 3.8M
- SXTP 2.7M
- IPO Year
- TCRT N/A
- SXTP 2023
- Fundamental
- Price
- TCRT $3.01
- SXTP $2.26
- Analyst Decision
- TCRT
- SXTP Hold
- Analyst Count
- TCRT 0
- SXTP 1
- Target Price
- TCRT N/A
- SXTP N/A
- AVG Volume (30 Days)
- TCRT 49.8K
- SXTP 457.4K
- Earning Date
- TCRT 05-19-2025
- SXTP 05-19-2025
- Dividend Yield
- TCRT N/A
- SXTP N/A
- EPS Growth
- TCRT N/A
- SXTP N/A
- EPS
- TCRT N/A
- SXTP N/A
- Revenue
- TCRT $10,000.00
- SXTP $681,345.00
- Revenue This Year
- TCRT $5,680,500.00
- SXTP $95.50
- Revenue Next Year
- TCRT N/A
- SXTP $80.78
- P/E Ratio
- TCRT N/A
- SXTP N/A
- Revenue Growth
- TCRT 100.00
- SXTP 168.70
- 52 Week Low
- TCRT $1.31
- SXTP $1.41
- 52 Week High
- TCRT $14.20
- SXTP $36.00
- Technical
- Relative Strength Index (RSI)
- TCRT 60.22
- SXTP 43.50
- Support Level
- TCRT $2.56
- SXTP $2.21
- Resistance Level
- TCRT $2.91
- SXTP $2.45
- Average True Range (ATR)
- TCRT 0.28
- SXTP 0.44
- MACD
- TCRT 0.02
- SXTP -0.09
- Stochastic Oscillator
- TCRT 100.00
- SXTP 6.86
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.